Last reviewed · How we verify

NCT04922749: MULTI+

Evaluation of a Multidisciplinary Lifestyle Treatment for Inpatients With Mental Illness

Status unknown NA Last updated 16 November 2021
What this trial tests

NA trial testing MULTI+ in Mental Illness in 846 participants. Status unknown.

Timeline
1 July 2020
Primary endpoint
1 September 2022
1 September 2022

Quick facts

Lead sponsorGGZ Centraal
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designsequential
Maskingnone
Primary purposetreatment
Enrollment846
Start date1 July 2020
Primary completion1 September 2022
Estimated completion1 September 2022
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

GGZ Centraal

Who can join

16 and older, any sex, with Mental Illness or Lifestyle. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

People with mental illness (MI) have a reduced life expectancy compared to the general population, mostly attributable to somatic diseases caused by poor physical health. Modifiable "lifestyle factors" have been increasingly associated with the onset of somatic diseases in people with MI and refer to health behaviours such as physical activity (PA), diet, sleep and smoking behaviour. Despite the evidence demonstrating the efficacy of interventions aimed at improving lifestyle factors, there have not been many structural changes in routine clinical care for people with MI. Using a multidisciplinary, multicomponent approach, Deenik and colleagues (2019) were the first to find long-term positive effects in both mental and somatic health in a real-world inpatient setting for people with severe mental illness (SMI). They found improvements in metabolic health, psychosocial functioning and quality of life, and a reduction in the use of psychotropic medication. The authors urged to confirm and complement findings in scaled-up studies, and made several suggestions for improvement of the treatment and pragmatic research of implementation. In line with these previous recommendations the MULTI is being scaled-up into the MULTI+. This study investigates the implementation and effectiveness of a multidisciplinary lifestyle treatment for inpatients with mental illness (MULTI+).

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effectiveness and implementation of a multidisciplinary lifestyle focused approach in the treatment of inpatients with mental illness (MULTI +): a stepped wedge study protocol.
    den Bleijker NM, van Schothorst MME, Hendriksen IJM, Cahn W, et al · · 2022 · cited 4× · PMID 35361168 · DOI 10.1186/s12888-022-03801-w
  2. Evaluating the Impact of a Lifestyle-Focused Approach on Cardiovascular Risk in Inpatients With Mental Illness: Analyzing Effectiveness and Fidelity in a Stepped Wedge Cluster Randomized Trial (MULTI+ Study V).
    den Bleijker NM, van Schothorst MME, Reitsma JB, Hendriksen IJM, et al · · 2025 · PMID 40932842 · DOI 10.1176/appi.prcp.20240150
  3. Barriers and facilitators of inpatients and healthcare professionals prior to the implementation of a Multidisciplinary Lifestyle-Focused Approach in the Treatment of Inpatients With Mental Illness (MULTI+): The MULTI+ Study II.
    van Schothorst MME, den Bleijker NM, van Harten PN, De Vries NK, et al · · 2025 · PMID 40630921 · DOI 10.1177/26334895251351663
  4. A network approach to lifestyle behaviors and health outcomes in people with mental illness: the MULTI+ study III.
    den Bleijker NM, van Schothorst MME, Blanken TF, Hendriksen IJM, et al · · 2025 · PMID 40211776 · DOI 10.1192/j.eurpsy.2025.2442

Verify or expand the search:

Other recruiting trials for Mental Illness

Currently open trials in the same condition.

Other GGZ Centraal trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04922749.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing